UBS Group’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-392,884
Closed -$18.5M 10907
2025
Q2
$18.5M Sell
392,884
-233,546
-37% -$10.4M ﹤0.01% 2445
2025
Q1
$27.6M Buy
626,430
+404,252
+182% +$18.6M 0.01% 2028
2024
Q4
$8.03M Buy
222,178
+87,499
+65% +$3.06M ﹤0.01% 3304
2024
Q3
$4.32M Sell
134,679
-925
-0.7% -$34.6K ﹤0.01% 3226
2024
Q2
$5.11M Sell
135,604
-77,929
-36% -$3.28M ﹤0.01% 2859
2024
Q1
$10.5M Buy
213,533
+73,861
+53% +$3.41M ﹤0.01% 2226
2023
Q4
$5.1M Buy
139,672
+108,966
+355% +$2.84M ﹤0.01% 2766
2023
Q3
$710K Sell
30,706
-53,229
-63% -$1.46M ﹤0.01% 4379
2023
Q2
$2.2M Sell
83,935
-2,341
-3% -$61.5K ﹤0.01% 3432
2023
Q1
$2.22M Sell
86,276
-62,840
-42% -$1.84M ﹤0.01% 3306
2022
Q4
$3.88M Buy
149,116
+100,204
+205% +$2.47M ﹤0.01% 2741
2022
Q3
$1.4M Sell
48,912
-33,035
-40% -$947K ﹤0.01% 3464
2022
Q2
$2.02M Sell
81,947
-1,957
-2% -$71.6K ﹤0.01% 3144
2022
Q1
$4.74M Buy
83,904
+58,991
+237% +$3.38M ﹤0.01% 2592
2021
Q4
$1.54M Sell
24,913
-18,047
-42% -$1.19M ﹤0.01% 3976
2021
Q3
$2.73M Buy
42,960
+40,485
+1,636% +$3.12M ﹤0.01% 3300
2021
Q2
$204K Sell
2,475
-43,633
-95% -$3.31M ﹤0.01% 5325
2021
Q1
$3.39M Buy
46,108
+44,091
+2,186% +$3.45M ﹤0.01% 3007
2020
Q4
$147K Buy
2,017
+1,541
+324% +$99.2K ﹤0.01% 5443
2020
Q3
$23K Buy
+476
New +$20.3K ﹤0.01% 6211
2020
Q2
Sell
-388
Closed -$10K 8342
2020
Q1
$10K Sell
388
-1,952
-83% -$63.6K ﹤0.01% 6939
2019
Q4
$90K Sell
2,340
-4
-0.2% -$94 ﹤0.01% 6063
2019
Q3
$51K Buy
+2,344
New +$55.4K ﹤0.01% 6193

Other funds holding SWTX